Related Experiment Video
Updated: Aug 9, 2026

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
Published on: September 27, 2024
Diadenosines as FHIT-ness instructors
Manuela Campiglio1, Francesca Bianchi, Francesca Andriani
1Department of Experimental Oncology, Molecular Biology Unit, Istituto Nazionale Tumori, Milan, Italy. manuela.campiglio@istitutotumori.mi.it
Abstract:
FHIT is a tumor suppressor gene that is frequently inactivated in human cancer. Although the Fhit protein is known to hydrolyze diadenosine triphosphate (Ap(3)A), this hydrolase activity is not required for Fhit-mediated oncosuppression. Indeed, the molecular mechanisms and the regulatory elements of Fhit oncosuppression are largely unknown. Here, we review physiological and pathological aspects of Fhit in the context of the Ap(n)A family of signaling molecules, as well as the involvement of Fhit in apoptosis and the cell cycle in cancer models. We also discuss recent findings of novel Fhit interactions that may lead to new hypotheses about biochemical mechanisms underlying the oncosuppressor activity of this gene.
Insights
The FHIT gene, a tumor suppressor, is often inactivated in human cancers. Its precise oncosuppressive mechanisms and interactions, beyond its known hydrolase activity, are still being explored in cancer research.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- The Fragile Histidine Triad (FHIT) gene functions as a tumor suppressor, frequently inactivated in various human cancers.
- While Fhit protein's diadenosine triphosphate (Ap3A) hydrolase activity is established, it's not essential for its tumor-suppressive role.
- The molecular pathways and regulatory elements governing FHIT's oncosuppression remain largely unelucidated.
Purpose of the Study:
- To review the physiological and pathological roles of FHIT in relation to Ap(n)A signaling molecules.
- To explore the involvement of FHIT in apoptosis and cell cycle regulation within cancer models.
- To discuss novel FHIT interactions that may reveal new hypotheses on its biochemical oncosuppressor mechanisms.
Main Methods:
- Literature review of existing studies on FHIT.
- Analysis of FHIT's role in Ap(n)A signaling pathways.
- Examination of FHIT's involvement in apoptosis and cell cycle control.
- Discussion of recent findings on FHIT protein interactions.
Main Results:
- FHIT's tumor suppressor function is independent of its Ap3A hydrolase activity.
- FHIT is implicated in regulating apoptosis and cell cycle progression in cancer.
- Emerging evidence points to novel protein interactions influencing FHIT's oncosuppressive activity.
Conclusions:
- The precise biochemical mechanisms of FHIT's tumor suppressor activity are complex and not fully understood.
- Further research into FHIT's interactions and its role in signaling pathways is crucial for understanding its oncosuppressive function.
- FHIT remains a significant target for cancer research due to its established role as a tumor suppressor gene.
More Related Videos
05:58A Novel Nicotinamide Adenine Dinucleotide Correction Method for Intracellular Ca2+ Measurement with Fura-2-Analog in Live Cells
Published on: September 20, 2019
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
FISH - Fluorescent In-situ Hybridization
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...